To date, 2024 has not yet seen the type of mega-merger (Pfizer/Seagen) or level of agency enforcement (Sanofi/Maze or Amgen/Horizon) as 2023. But two notable investigations — one still active — show the Federal Trade...more
9/10/2024
/ AbbVie ,
Abuse of Dominance ,
Acquisitions ,
Amgen ,
Antitrust Investigations ,
Antitrust Provisions ,
Eli Lilly ,
EU ,
European Commission ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Horizontal Mergers ,
Life Sciences ,
Mergers ,
Orange Book ,
Patents ,
Pfizer ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Popular ,
Sanofi ,
Supply Chain ,
Vertical Mergers
Two major technology companies, Meta and Microsoft, continue to defend their acquisitions against challenges from antitrust regulators. The FTC dropped one of the two claims underlying its challenge of Meta’s acquisition of...more
11/10/2022
/ Acquisitions ,
Antitrust Investigations ,
Antitrust Provisions ,
Competition ,
EU ,
European Commission ,
Facebook ,
Federal Trade Commission (FTC) ,
Mergers ,
Microsoft ,
Mobile Apps ,
Popular ,
UK ,
UK Competition and Markets Authority (CMA)
In July 2022, the FTC brought an enforcement action to enjoin Meta’s acquisition of virtual reality app maker Within. The FTC’s approach in that complaint could have implications for Microsoft’s proposed acquisition of...more
8/16/2022
/ Acquisitions ,
Amazon ,
Antitrust Investigations ,
Antitrust Provisions ,
App Developers ,
Big Tech ,
Broadcom ,
Facebook ,
Federal Trade Commission (FTC) ,
Google ,
Horizontal Mergers ,
Microsoft ,
Mobile Apps ,
Popular ,
Vertical Mergers ,
Video Games ,
Virtual Reality